Abstract:
One aspect of the invention provides a wearable device including: at least one compliant region adapted and configured to be placed over a joint of a subject and at least two flexible but less compliant regions coupled to opposite ends of the compliant region. Another aspect of the invention provides a wearable robotic device including a wearable device as described herein and at least one actuator adapted and configured to move the flexible but less compliant regions relative to each other.
Abstract:
A network having an access service network ("ASN") configured to provide full mobility to mobile stations located within a service area. The ASN includes a Layer 2 or data link layer network that is larger, incorporates more nodes, or carries more data communications than Layer 2 networks incorporated in prior art ASNs. Data communications to and from the mobile stations are routed inside the ASN across the Layer 2 network which transports the data communication using a Layer 2 protocol. If the network includes another ASN located adjacent to the first ASN, the two ASNs may communicate directly with one another over a Layer 2 connection. If the network includes another ASN that is not adjacent to the first, Mobile Internet Protocol components may be included in the ASNs and configured to provide mobility between ASNs.
Abstract:
The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective beta 3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity. The invention provides compounds and method of treating Type II diabetes, comprising administering to a mammal in need thereof compounds of Formulas (I) and (II).
Abstract:
Filtration systems (40) utilize a pre-treatment method to cause scale formation to occur on particles (94) in the fluid stream (96) rather than on the filter surface and may also destroy microorganisms in the fluid stream. More specifically, but not limited to, a filtration device can be a filtration membrane, such as spiral wound filtration membrane (60), that utilizes an open feed spacer (80), such for example an embossed or printed pattern on the membrane, to create a thin feed spacer channel which replaces a conventional feed spacer mesh material. System (40) further utilizes a treatment device (54) to enable a pulsed power, magnetic, electro-magnetic, electro-static, or hydrodynamic fluid treatment scheme to condition particles in the fluid stream (96) such that scale forming elements precipitate (94) on to the particles in the fluid stream rather than on the filtration surfaces.
Abstract:
A network having an access service network ("ASN") configured to provide full mobility to mobile stations located within a service area. The ASN includes a Layer 2 or data link layer network that is larger, incorporates more nodes, or carries more data communications than Layer 2 networks incorporated in prior art ASNs. Data communications to and from the mobile stations are routed inside the ASN across the Layer 2 network which transports the data communication using a Layer 2 protocol. If the network includes another ASN located adjacent to the first ASN, the two ASNs may communicate directly with one another over a Layer 2 connection. If the network includes another ASN that is not adjacent to the first, Mobile Internet Protocol components may be included in the ASNs and configured to provide mobility between ASNs.
Abstract:
A method for authenticating a workflow that has one or more designated steps that require authentication of associated resources, the method comprising: using a reader instrument to read at least one security feature uniquely associated resources involved in the workflow; authenticating the security feature, thereby to authenticate its associated resource, and recording authentication information for each designated workflow step.
Abstract:
This invention provides a series of substituted benzo[b]thiophenes useful in reversing multidrug resistance in a resistant neoplasm. The present invention also provides methods for reversing the multidrug resistance in a resistant neoplasm by treating a mammal in need of said treatment with a substituted benzothiophene. This invention also provides methods for treating neoplasms in a mammal which comprises administering to a mammal in need of this treatment a substituted benzothiophene in combination with an oncolytic agent.
Abstract:
Filtration systems (40) utilize a pre-treatment method to cause scale formation to occur on particles (94) in the fluid stream (96) rather than on the filter surface and may also destroy microorganisms in the fluid stream. More specifically, but not limited to, a filtration device can be a filtration membrane, such as spiral wound filtration membrane (60), that utilizes an open feed spacer (80), such for example an embossed or printed pattern on the membrane, to create a thin feed spacer channel which replaces a conventional feed spacer mesh material. System (40) further utilizes a treatment device (54) to enable a pulsed power, magnetic, electro-magnetic, electro-static, or hydrodynamic fluid treatment scheme to condition particles in the fluid stream (96) such that scale forming elements precipitate (94) on to the particles in the fluid stream rather than on the filtration surfaces.
Abstract:
A subscriber management system for a communication system having a radio access network coupled to by a gateway node to a packet switched network. The system consolidates three prior art subscriber management system components, a DPI device, a QoS Policy Manager 40, and an Application Manager 28, into a DPI platform. The system also relocates functions to the DPI platform that were previously provided by the gateway node in prior art networks. Specifically, an Accounting Client 34, a Hotlining function 36, and a QoS SFA function 44 are located to the DPI platform. By consolidating network components and relocating functions to the DPI platform, the number of control interfaces in the network can be reduced. Further, network components produced by different vendors may be integrated more easily. A method of implementing hotlining in the system is also provided.
Abstract:
One aspect of the invention provides a wearable device including: at least one compliant region adapted and configured to be placed over a joint of a subject and at least two flexible but less compliant regions coupled to opposite ends of the compliant region. Another aspect of the invention provides a wearable robotic device including a wearable device as described herein and at least one actuator adapted and configured to move the flexible but less compliant regions relative to each other.